[2]
Borgers M,Degreef H,Cauwenbergh G, Fungal infections of the skin: infection process and antimycotic therapy. Current drug targets. 2005 Dec;
[PubMed PMID: 16375669]
[3]
Agut J, Palacín C, Salgado J, Casas E, Sacristán A, Ortiz JA. Direct membrane-damaging effect of sertaconazole on Candida albicans as a mechanism of its fungicidal activity. Arzneimittel-Forschung. 1992 May:42(5A):721-4
[PubMed PMID: 1627191]
[4]
Patel V,Liaw B,Oh W, The role of ketoconazole in current prostate cancer care. Nature reviews. Urology. 2018 Oct;
[PubMed PMID: 30154429]
[5]
Van Tyle JH, Ketoconazole. Mechanism of action, spectrum of activity, pharmacokinetics, drug interactions, adverse reactions and therapeutic use. Pharmacotherapy. 1984 Nov-Dec;
[PubMed PMID: 6151171]
[6]
Hu Z,He B,Ma L,Sun Y,Niu Y,Zeng B, Recent Advances in Ergosterol Biosynthesis and Regulation Mechanisms in {i}Saccharomyces cerevisiae{/i}. Indian journal of microbiology. 2017 Sep;
[PubMed PMID: 28904410]
Level 3 (low-level) evidence
[7]
Bhasin S, Sikka S, Fielder T, Sod-Moriah U, Levine HB, Swerdloff RS, Rajfer J. Hormonal effects of ketoconazole in vivo in the male rat: mechanism of action. Endocrinology. 1986 Mar:118(3):1229-32
[PubMed PMID: 3081326]
[8]
Engelhardt D,Weber MM,Miksch T,Abedinpour F,Jaspers C, The influence of ketoconazole on human adrenal steroidogenesis: incubation studies with tissue slices. Clinical endocrinology. 1991 Aug;
[PubMed PMID: 1934533]
[9]
Loli P,Berselli ME,Tagliaferri M, Use of ketoconazole in the treatment of Cushing's syndrome. The Journal of clinical endocrinology and metabolism. 1986 Dec;
[PubMed PMID: 3023421]
[10]
Piérard-Franchimont C,De Doncker P,Cauwenbergh G,Piérard GE, Ketoconazole shampoo: effect of long-term use in androgenic alopecia. Dermatology (Basel, Switzerland). 1998;
[PubMed PMID: 9669136]
[11]
Khozeimeh F, Shahtalebi MA, Noori M, Savabi O. Comparative evaluation of ketoconazole tablet and topical ketoconazole 2% in orabase in treatment of Candida-infected denture stomatitis. The journal of contemporary dental practice. 2010 Mar 1:11(2):017-24
[PubMed PMID: 20228983]
Level 2 (mid-level) evidence
[13]
Gupta AK, Daigle D, Foley KA. Drug safety assessment of oral formulations of ketoconazole. Expert opinion on drug safety. 2015 Feb:14(2):325-34. doi: 10.1517/14740338.2015.983071. Epub 2014 Nov 20
[PubMed PMID: 25409549]
Level 3 (low-level) evidence
[14]
DeFelice R, Johnson DG, Galgiani JN. Gynecomastia with ketoconazole. Antimicrobial agents and chemotherapy. 1981 Jun:19(6):1073-4
[PubMed PMID: 6267997]
[15]
Gupta AK,Lyons DC, The Rise and Fall of Oral Ketoconazole. Journal of cutaneous medicine and surgery. 2015 Jul-Aug;
[PubMed PMID: 25775613]
[16]
Choi FD, Juhasz MLW, Atanaskova Mesinkovska N. Topical ketoconazole: a systematic review of current dermatological applications and future developments. The Journal of dermatological treatment. 2019 Dec:30(8):760-771. doi: 10.1080/09546634.2019.1573309. Epub 2019 Feb 14
[PubMed PMID: 30668185]
Level 1 (high-level) evidence
[17]
Daneshmend TK,Warnock DW, Clinical pharmacokinetics of ketoconazole. Clinical pharmacokinetics. 1988 Jan;
[PubMed PMID: 3280211]
[18]
Kempen HJ, van Son K, Cohen LH, Griffioen M, Verboom H, Havekes L. Effect of ketoconazole on cholesterol synthesis and on HMG-CoA reductase and LDL-receptor activities in Hep G2 cells. Biochemical pharmacology. 1987 Apr 15:36(8):1245-9
[PubMed PMID: 3036162]
[19]
Lee HC, Tl Huang K, Shen WK. Use of antiarrhythmic drugs in elderly patients. Journal of geriatric cardiology : JGC. 2011 Sep:8(3):184-94. doi: 10.3724/SP.J.1263.2011.00184. Epub
[PubMed PMID: 22783304]
[20]
McGregor JA, Pont A. Contraindication of ketoconazole in pregnancy. American journal of obstetrics and gynecology. 1984 Nov 15:150(6):793-4
[PubMed PMID: 6093540]
[21]
Yan JY,Nie XL,Tao QM,Zhan SY,Zhang YD, Ketoconazole associated hepatotoxicity: a systematic review and meta- analysis. Biomedical and environmental sciences : BES. 2013 Jul;
[PubMed PMID: 23895707]
Level 1 (high-level) evidence